Evidence map›Paper›PMID 14632637›Full record

ReviewImmunology2003

B-cell antigen-receptor signalling in lymphocyte development.

Leo D Wang, Marcus R Clark

Open access · greenAbstract readReview
In one paragraph

Review in Immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Role of B cells as antigen presenting cells.Frontiers in immunology · 2022
    Review
  8. FCRL1 Regulates B Cell Receptor-Induced ERK Activation through GRB2.Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  17. Article
  18. Review
  19. Conserved HIV Epitopes for an Effective HIV Vaccine.Journal of clinical & cellular immunology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Leo D WangSection of Rheumatology and Committee on Immunology, Biological Sciences Division and Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA. leo@uchicago.edu
Marcus R Clark
University of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signalling through the B-cell antigen receptor (BCR) is required throughout B-cell development and peripheral maturation. Targeted disruption of BCR components or downstream effectors indicates that specific signalling mechanisms are preferentially required for central B-cell development, peripheral maturation and repertoire selection. Additionally, the avidity and the context in which antigen is encountered determine both cell fate and differentiation in the periphery. Although the signalling and receptor components required at each stage have been largely elucidated, the molecular mechanisms through which specific signalling are evoked at each stage are still obscure. In particular, it is not known how the pre-BCR initiates the signals required for normal development or how immature B cells regulate the signalling pathways that determine cell fate. In this review, we will summarize the recent studies that have defined the molecules required for B-cell development and maturation as well as the theories on how signals may be regulated at each stage.

Indexed as

Membrane ProteinsAnimalsB-Cell Activation Factor ReceptorB-LymphocytesCell DifferentiationCytoplasmHumansImmunoglobulinsInterleukin-7Models, ImmunologicalReceptors, Antigen, B-CellReceptors, Tumor Necrosis FactorSignal TransductionB-Cell Activation Factor ReceptorImmunoglobulinsInterleukin-7Membrane ProteinsReceptors, Antigen, B-CellReceptors, Tumor Necrosis FactorTNFRSF13C protein, human

Identifiers

PMID14632637
PMCPMC1783068
OpenAlexW2014436895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.